AFP and hepatocellular carcinoma: The α-FAtE score, which is based on alpha-fetoprotein (AFP), alkaline phosphatase (ALP), and eosinophil, is a new predictive score that could predict the response and prognosis of HCC patients who treated with atezolizumab plus bevacizumab (15).